Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
O'Neil, Daniel
ATEMPT 2.0, NCT04893109: Adjuvant T-DM1 Vs TH	Recruiting	2	500	US	trastuzumab-emtansine, T-DM1, Kadcyla, Trastuzumab SC, Herceptin Hylecta, Paclitaxel, Taxol, Onxal	Dana-Farber Cancer Institute, Genentech, Inc.	Breast Cancer, HER2-positive Breast Cancer	05/25	05/28
NCT06233383: Developing Screening Clinical Breast Examination Implementation Strategies in South Africa	Recruiting	N/A	60	RoW		Yale University, University of Witwatersrand, South Africa	Breast Cancer	06/25	06/25
Joffe, Maureen
NCT06233383: Developing Screening Clinical Breast Examination Implementation Strategies in South Africa	Recruiting	N/A	60	RoW		Yale University, University of Witwatersrand, South Africa	Breast Cancer	06/25	06/25